Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 2201-2208

  Nunes Cabaço, Helena ^a   Matoso, Paula ^a   Foxall, Russell B ^a   Tendeiro, Rita ^a,b   Pires, Ana R ^a   Carvalho, Tânia ^a   Pinheiro, Ana I ^a   Soares, Rui S ^a   Sousa, Ana E ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN; MESSENGER RNA; VIRUS DNA; VIRUS RNA;

ARTICLE; CELL DIFFERENTIATION; CELL SUSPENSION; CHILD; CONTROLLED STUDY; DEVELOPMENTAL STAGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN TISSUE; INFECTION CONTROL; NEWBORN; NONHUMAN; ORGAN CULTURE; PRESCHOOL CHILD; T LYMPHOCYTE; THYMOCYTE; THYMUS DISEASE; TISSUE SECTION; TRANSCRIPTION REGULATION; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; ADULT; CELL CULTURE; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFANT; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PHYSIOLOGY; THYMUS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ADULT; CELLS, CULTURED; CHILD, PRESCHOOL; HIV-1; HIV-2; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INFANT, NEWBORN; ORGAN CULTURE TECHNIQUES; THYMOCYTES; THYMUS GLAND; VIRUS REPLICATION;

EID: 84921633227     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03047-14     Document Type: Article

References (51)

1. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690-695. http://dx.doi.org/10.1038/25374.
2. Nunes-Cabaço H, Sousa AE. 2013. Repairing thymic function. Curr Opin Organ Transplant 18:363-368. http://dx.doi.org/10.1097/MOT.0b013e3283615df9.
3. Dion ML, Poulin JF, Bordi R, Sylvestre M, Corsini R, Kettaf N, Dalloul A, Boulassel MR, Debre P, Routy JP, Grossman Z, Sekaly RP, Cheynier R. 2004. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21:757-768. http://dx.doi.org/10.1016/j.immuni.2004.10.013.
4. Li T, Wu N, Dai Y, Qiu Z, Han Y, Xie J, Zhu T, Li Y. 2011. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis 53:944-951. http://dx.doi.org/10.1093/cid/cir552.
5. Haynes BF, Hale LP, Weinhold KJ, Patel DD, Liao H-X, Bressler PB, Jones DM, Demarest JF, Gebhard-Mitchell K, Haase AT, Bartlett JA. 1999. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103:453-460. http://dx.doi.org/10.1172/JCI5201.
6. Joshi VV, Oleske JM, Saad S, Gadol C, Connor E, Bobila R, Minnefor AB. 1986. Thymus biopsy in children with acquired immunodeficiency syndrome. Arch Pathol Lab Med 110:837-842.
7. Bonyhadi ML, Su L, Auten J, McCune JM, Kaneshima H. 1995. Development of a human thymic organ culture model for the study of HIV pathogenesis. AIDS Res Hum Retroviruses 11:1073-1080. http://dx.doi.org/10.1089/aid.1995.11.1073.
8. Choudhary SK, Choudhary NR, Kimbrell KC, Colasanti J, Ziogas A, Kwa D, Schuitemaker H, Camerini D. 2005. R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression. J Virol 79:458-471. http://dx.doi.org/10.1128/JVI.79.1.458-471.2005.
9. Gurney KB, Uittenbogaart CH. 2006. Human immunodeficiency virus persistence and production in T-cell development. Clin Vaccine Immunol 13:1237-1245. http://dx.doi.org/10.1128/CVI.00184-06.
10. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H. 1993. HIV induces thymus depletion in vivo. Nature 363: 728-732. http://dx.doi.org/10.1038/363728a0.
11. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J. 1993. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 178:1151-1163. http://dx.doi.org/10.1084/jem.178.4.1151.
12. Pedroza-Martins L, Gurney KB, Torbett BE, Uittenbogaart CH. 1998. Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level. J Virol 72:9441-9452.
13. Berkowitz RD, Alexander S, Bare C, Linquist-Stepps V, Bogan M, Moreno ME, Gibson L, Wieder ED, Kosek J, Stoddart CA, McCune JM. 1998. CCR5-and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol 72:10108-10117.
14. Dutrieux J, Fabre-Mersseman V, Charmeteau-De Muylder B, Rancez M, Ponte R, Rozlan S, Figueiredo-Morgado S, Bernard A, Beq S, Couëdel-Courteille A, Cheynier R. 2014. Modified interferon- subtypes production and chemokine networks in the thymus during acute simian immunodeficiency virus infection, impact on thymopoiesis. AIDS 28: 1101-1113. http://dx.doi.org/10.1097/QAD.0000000000000249.
15. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1590. http://dx.doi.org/10.1126/science.7915856.
16. Poulsen AG, Aaby P, Larsen O, Jensen H, Nauclér A, Lisse IM, Christiansen CB, Dias F, Melbye M. 1997. 9-year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 349:911-914. http://dx.doi.org/10.1016/S0140-6736(96)04402-9.
17. Clavel F, Mansinho K, Chamaret S, Guetard D, Favier V, Nina J, Santos-Ferreira MO, Champalimaud JL, Montagnier L. 1987. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 316:1180-1185. http://dx.doi.org/10.1056/NEJM198705073161903.
18. Popper SJ, Sarr AD, Gueye-NDiaye A, Mboup S, Essex ME, Kanki PJ. 2000. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol 74: 1554-1557. http://dx.doi.org/10.1128/JVI.74.3.1554-1557.2000.
19. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino R. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169:3400-3406. http://dx.doi.org/10.4049/jimmunol.169.6.3400.
20. Kanki PJ, Travers KU, Mboup S, Hsieh CC, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Avila M, Sankalé JL. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946. http://dx.doi.org/10.1016/S0140-6736(94)90065-5.
21. O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, Whittle H. 2000. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in the Gambia. MRC/Gambia Government/University College London Medical School Working Group on Mother-Child Transmission of HIV. AIDS 14:441-448.
22. Poulsen AG, Aaby P, Gottschau A, Kvinesdal BB, Dias F, Mølbak K, Lauritzen E. 1993. HIV-2 infection in Bissau, West Africa, 1987-1989: incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr 6:941-948.
23. Soares R, Foxall R, Albuquerque A, Cortesao C, Garcia M, Victorino RMM, Sousa AE. 2006. Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection. J Virol 80: 12425-12429. http://dx.doi.org/10.1128/JVI.01557-06.
24. Soares RS, Tendeiro R, Foxall RB, Baptista AP, Cavaleiro R, Gomes P, Camacho R, Valadas E, Doroana M, Lucas M, Antunes F, Victorino RMM, Sousa AE. 2011. Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. J Virol 85: 2429-2438. http://dx.doi.org/10.1128/JVI.01921-10.
25. Gautier D, Beq S, Cortesao CS, Sousa AE, Cheynier R. 2007. Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection. J Virol 81:12685-12688. http://dx.doi.org/10.1128/JVI.01131-07.
26. Borrego P, Marcelino J, Rocha C, Doroana M, Antunes F, Maltez F, Gomes P, Novo C, Barroso H, Taveira N. 2008. The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients. Retrovirology 5:78. http://dx.doi.org/10.1186/1742-4690-5-78.
27. Marcelino JM, Borrego P, Nilsson C, Família C, Barroso H, Maltez F, Doroana M, Antunes F, Quintas A, Taveira N. 2012. Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism. AIDS 26:2275-2284. http://dx.doi.org/10.1097/QAD.0b013e328359a89d.
28. Soares RS, Matoso P, Calado M, Sousa AE. 2011. Strategies to quantify unspliced and multiply spliced mRNA expression in HIV-2 infection. J Virol Methods 175:38-45. http://dx.doi.org/10.1016/j.jviromet.2011.04.012.
29. Pizzato M, Erlwein O, Bonsall D, Kaye S, Muir D, McClure MO. 2009. A one-step SYBR green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J Virol Methods 156:1-7. http://dx.doi.org/10.1016/j.jviromet.2008.10.012.
30. Vermeire J, Naessens E, Vanderstraeten H, Landi A, Iannucci V, Van Nuffel A, Taghon T, Pizzato M, Verhasselt B. 2012. Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti-and retroviral vectors. PLoS One 7:e50859. http://dx.doi.org/10.1371/journal.pone.0050859.
31. Nunes-Cabaço H, Caramalho Í Sepúlveda N, Sousa AE. 2011. Differentiation of human thymic regulatory T cells at the double positive stage. Eur J Immunol 41:3604-3614. http://dx.doi.org/10.1002/eji.201141614.
32. Fabre-Mersseman V, Dutrieux J, Louise A, Rozlan S, Lamine A, Parker R, Rancez M, Nunes-Cabaço H, Sousa AE, Lambotte O, Cheynier R. 2011. CD4+ recent thymic emigrants are infected by HIV in vivo, implication for pathogenesis. AIDS 25:1153-1162. http://dx.doi.org/10.1097/QAD.0b013e3283471e89.
33. Hizi A, Tal R, Shaharabany M, Loya S. 1991. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem 266:6230-6239.
34. Fernandes SM, Pires AR, Ferreira C, Tendeiro R, Correia L, Paulo SE, Victorino RMM, Sousa AE. 2014. Gut disruption in HIV-2 infection despite reduced viremia. AIDS 28:290-292. http://dx.doi.org/10.1097/QAD.0000000000000114.
35. Duvall MG, Lore K, Blaak H, Ambrozak DA, Adams WC, Santos K, Geldmacher C, Mascola JR, McMichael AJ, Jaye A, Whittle HC, Rowland-Jones SL, Koup RA. 2007. Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol 81:13486-13498. http://dx.doi.org/10.1128/JVI.00976-07.
36. Cavaleiro R, Sousa AE, Loureiro A, Victorino RMM. 2000. Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS 14:2679-2686. http://dx.doi.org/10.1097/00002030-200012010-00007.
37. Cavaleiro R, Brunn GJ, Albuquerque AS, Victorino RMM, Platt JL, Sousa AE. 2007. Monocyte-mediated T cell suppression by HIV-2 envelope proteins. Eur J Immunol 37:3435-3444. http://dx.doi.org/10.1002/eji.200737511.
38. Cavaleiro R, Baptista AP, Foxall RB, Victorino RMM, Sousa AE. 2009. Dendritic cell differentiation and maturation in the presence of HIV type 2 envelope. AIDS ResHumRetroviruses 25:425-431. http://dx.doi.org/10.1089/aid.2008.0247.
39. MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. 2007. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol 81:5325-5330. http://dx.doi.org/10.1128/JVI.02625-06.
40. Suspene R, Meyerhans A. 2012. Quantification of unintegrated HIV-1 DNA at the single cell level in vivo. PLoS One 7:e36246. http://dx.doi.org/10.1371/journal.pone.0036246.
41. Mörner A, Björndal Å, Albert J, KewalRamani VN, Littman DR, Inoue R, Thorstensson R, Fenyö EM, Björling E. 1999. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 73:2343-2349.
42. Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA. 2000. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol 74:9594-9600. http://dx.doi.org/10.1128/JVI.74.20.9594-9600.2000.
43. Schmitt N, Nugeyre M-T, Scott-Algara D, Cumont M-C, Barré-Sinoussi F, Pancino G, Israël N. 2006. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection. AIDS 20:533-542. http://dx.doi.org/10.1097/01.aids.0000210607.63138.bc.
44. Rozmyslowicz T, Murphy SL, Conover DO, Gaulton GN. 2010. HIV-1 infection inhibits cytokine production in human thymic macrophages. Exp Hematol 38:1157-1166. http://dx.doi.org/10.1016/j.exphem.2010.08.009.
45. Braun J, Valentin H, Nugeyre M-T, Ohayon H, Gounon P, Barré-Sinoussi F. 1996. Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1. Virology 225:413-418. http://dx.doi.org/10.1006/viro.1996.0617.
46. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657. http://dx.doi.org/10.1038/nature10117.
47. Ricci EP, Soto-Rifo R, Herbreteau CH, Decimo D, Ohlmann T. 2008. Lentiviral RNAs can use different mechanisms for translation initiation. Biochem Soc Trans 36:690. http://dx.doi.org/10.1042/BST0360690.
48. Strong CL, Lanchy J-M, Dieng Sarr A, Kanki PJ, Lodmell JS. 2009. A 5'UTRspliced mRNA isoform is specialized for enhanced HIV-2 gag translation. J Mol Biol 391:426-437. http://dx.doi.org/10.1016/j.jmb.2009.06.046.
49. Soto-Rifo R, Limousin T, Rubilar PS, Ricci EP, Decimo D, Moncorge O, Trabaud MA, Andre P, Cimarelli A, Ohlmann T. 2012. Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation. Nucleic Acids Res 40:2653-2667. http://dx.doi.org/10.1093/nar/gkr1093.
50. Brooks DG, Kitchen SG, Kitchen C, Scripture-Adams DD, Zack JA. 2001. Generation of HIV latency during thymopoiesis. Nat Med 7:459-464. http://dx.doi.org/10.1038/86531.
51. Marini A, Harper JM, Romerio F. 2008. An in vitro system to model the establishment and reactivation of HIV-1 latency. J Immunol 181:7713-7720. http://dx.doi.org/10.4049/jimmunol.181.11.7713.